VIRTUAL PATENT MARKING

Sebela Pharmaceuticals is a manufacturer, distributor, and seller of pharmaceutical products in Women’s Health, Gastroenterology, and Dermatology. Sebela Pharmaceuticals’ products are sold by the company and may be from time to time sold and distributed by its commercial partners. This page is intended to serve as notice of patent coverage of products under 35 U.S.C. § 287(a).

SUTAB®
US10,143,656
US11,033,498
US11,382,864

SUPREP® BOWEL PREP KIT
US6,946,149

NAFTIN®
US8,778,365
US9,161,914
US10,166,205
US10,166,206
US10,695,303
US10,729,667

BRISDELLE®
US9,393,237
US8,946,251

PEXEVA®
US7,598,271

As used in this Virtual Patent Marking, the name “Sebela Pharmaceuticals” includes the following entities: Braintree Laboratories, Inc.; Sebela Women’s Health, Inc.; Sebela VLC; Sebela Ireland Limited; Sebela Pharmaceuticals, Inc.; Sebela International Limited; and Sebela International Bermuda Limited.